Clear Street, a cloud-native financial technology firm which aims to modernize the brokerage ecosystem, today announced the launch of its Equity Research Group, a strategic initiative aimed at providing in-depth market analysis and investment insights to its growing institutional client base.

Led by Director of Research Mara Goldstein, Clear Street Equity Research will focus initially on the Disruptive Technology, Energy Transition and Healthcare sectors, adding a new service offering for the company’s investment banking and prime brokerage clients.

“The launch of our equity research product complements our Equity Capital Markets, Debt Capital Markets, M&A Advisory and Corporate Access offerings and further builds out Clear Street’s value proposition, particularly for our expanding base of opportunistic hedge fund clients,” said Ed Tilly, President and CEO-Elect of Clear Street. “Adding equity research capabilities makes us even more comprehensive on top of our already existing services across prime brokerage, professional clearing, futures and professional trading, which has most recently been expanded by our acquisition of Instinet’s Fox River algorithmic trading business.”

To launch coverage, Clear Street has appointed Brian Dobson and Tim Moore, CFA as Managing Directors and Senior Research Analysts, reporting to Ms. Goldstein. Mr. Dobson will cover Disruptive Technology and Mr. Moore will cover Energy Transition. Additionally, Clear Street has appointed Kaveri Pohlman, Ph.D. and William Maughan as Managing Directors and Senior Equity Analysts. Both will cover Healthcare and report to Ms. Goldstein.

“The Disruptive Technology, Energy Transition and Healthcare sectors hold compelling opportunities for investors looking to capitalize on innovation,” said Ms. Goldstein. “Our goal is to deliver unique and insightful research that will add value for our clients and further strengthen Clear Street’s position in the market and I’m looking forward to working with Brian and Tim to achieve that.”

Mr. Dobson brings 20 years of capital markets experience to Clear Street, having held senior equity research positions at Jefferies, Nomura, Lazard Capital Markets and Susquehanna, and most recently serving as Head of Disruptive Technology & SPAC equity research at Chardan Capital Markets.

Tim Moore brings two decades of equity research experience to Clear Street, specializing in small and micro-cap stocks. Mr. Moore was part of the Institutional Investor All-America Research Team while at Lehman Brothers and brings 14 years of buy-side experience from roles at Invesco, Fort Washington/Touchstone and other firms.

Ms. Pohlman was previously Director, Equity Research at BTIG and Mr. Maughan was a Senior Biotechnology Analyst at Canaccord Genuity before joining Clear Street.